The American Society of Health System Pharmacists (ASHP) maintains a tool that helps track and report on medication shortages that may impact practices and patients. Recently, amphetamine mixed salts (immediate release and extended release) have been added to this list. The shortages may impact patients with ADHD who are taking generic forms of Adderall IR/ER®. If patients are having difficulty obtaining their medication, Partners For Kids maintains an ADHD prescribing resource that contains guidance on switching between stimulant medications. The prescribing resource also provides viable options that are covered by the Ohio Department of Medicaid’s Unified Preferred Drug List. The ASHP drug shortage tool provides timely updates on the status of the current shortage.
Mixed Amphetamine Salts (Adderall IR and ER®) Shortage Information
Related Articles
Flovent® Brand Name Inhalers Are Being Discontinued
Read More
PFK Asthma Risk Portal: Identify and Learn About Your High-Risk Asthma Patients
Learn more about the Asthma Risk Portal and view the training manual.
Read More
Update: Nirsevimab 100 mg Syringe Shortage
Learn more about the Nirsevimab 100 mg Syringe Shortage.
Read More
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List
Access the most recent unified preferred drug list.
Read More
Partners For Kids Coverage Tools Support Cost Savings and Decrease Prior Authorization Burden
Read how Partners For Kids pharmacy resources can help providers align therapy decisions with managed care organization’s formularies, generate cost savings and avoid prior authorizations.
Read More
Respiratory Syncytial Virus (RSV) Prevention Resource
Read More